Quarterly Results

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE6259.15-41.65 (-0.66 %)
PREV CLOSE ( ) 6300.80
OPEN PRICE ( ) 6324.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11810
TODAY'S LOW / HIGH ( )6200.05 6348.00
52 WK LOW / HIGH ( )4383.4 6505.5
NSE6257.60-35.85 (-0.57 %)
PREV CLOSE( ) 6293.45
OPEN PRICE ( ) 6329.90
BID PRICE (QTY) 6257.60 (54)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 317354
TODAY'S LOW / HIGH( ) 6200.00 6350.00
52 WK LOW / HIGH ( )4384.05 6505.9
Quarters
Select year  
( in Million)
Particulars
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
71138
72368
69026
67579
Total Expenditure
52826
52137
48943
46958
PBIDT (Excl OI)
18312
20231
20083
20621
Other Income
1975
2162
3150
1740
Operating Profit
20287
22393
23233
22361
Interest
593
394
353
371
Exceptional Items
NA
NA
NA
NA
PBDT
19694
21999
22880
21990
Depreciation
3677
3735
3755
3533
Profit Before Tax
16017
18264
19125
18457
Tax
2954
4482
4345
4450
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
13063
13782
14780
14007
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
13063
13782
14780
14007
Minority Interest
NA
NA
NA
NA
Shares of Associates
35
27
42
43
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
13098
13809
14822
14050
Equity Capital
834
834
834
833
Face Value (IN RS)
5
5
5
5
Reserves
NA
NA
NA
NA
Calculated EPS
78.52
82.78
88.86
84.33
Calculated EPS (Annualised)
314.10
331.15
355.44
337.33
No of Public Share Holdings
96749081
96772670
98945802
101208665
% of Public Share Holdings
58
58.02
59.32
60.76
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
25.74
27.95
29.09
30.51
PBIDTM%
28.51
30.94
33.65
33.08
PBDTM%
27.68
30.39
33.14
32.53
PBTM%
22.51
25.23
27.70
27.31
PATM%
18.36
19.04
21.41
20.72
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.